Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Dial S, Delaney JA, Barkun AN, Suissa S.

JAMA. 2005 Dec 21;294(23):2989-95.

PMID:
16414946
2.

Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.

Bauer MP, Goorhuis A, Koster T, Numan-Ruberg SC, Hagen EC, Debast SB, Kuijper EJ, van Dissel JT.

Neth J Med. 2008 May;66(5):207-11. Review.

3.

The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings.

Khanna S, Pardi DS.

Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):409-16. doi: 10.1586/egh.10.48. Review.

PMID:
20678014
4.

Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysis.

Furuya-Kanamori L, Stone JC, Clark J, McKenzie SJ, Yakob L, Paterson DL, Riley TV, Doi SA, Clements AC.

Infect Control Hosp Epidemiol. 2015 Feb;36(2):132-41. doi: 10.1017/ice.2014.39. Review.

PMID:
25632995
5.

Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.

Tariq R, Singh S, Gupta A, Pardi DS, Khanna S.

JAMA Intern Med. 2017 Jun 1;177(6):784-791. doi: 10.1001/jamainternmed.2017.0212. Review.

PMID:
28346595
6.

Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.

MacLaren R, Kassel LE, Kiser TH, Fish DN.

Expert Opin Drug Saf. 2015 Feb;14(2):269-80. doi: 10.1517/14740338.2015.986456. Epub 2014 Nov 25. Review.

PMID:
25423448
7.

Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?

Cunningham R, Dial S.

J Hosp Infect. 2008 Sep;70(1):1-6. doi: 10.1016/j.jhin.2008.04.023. Epub 2008 Jul 3. Review.

PMID:
18602190
8.

Recent changes in Clostridium difficile infection.

Silva Júnior M.

Einstein (Sao Paulo). 2012 Jan-Mar;10(1):105-9. Review.

9.

New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.

DuPont HL, Garey K, Caeiro JP, Jiang ZD.

Curr Opin Infect Dis. 2008 Oct;21(5):500-7. doi: 10.1097/QCO.0b013e32830f9397. Review.

PMID:
18725800
10.

Acid suppression and the risk of Clostridium difficile infection.

Mezoff EA, Cohen MB.

J Pediatr. 2013 Sep;163(3):627-30. doi: 10.1016/j.jpeds.2013.04.047. Epub 2013 Jun 5. Review. No abstract available.

11.

Clostridium difficile Infection in children.

Sammons JS, Toltzis P, Zaoutis TE.

JAMA Pediatr. 2013 Jun;167(6):567-73. doi: 10.1001/jamapediatrics.2013.441. Review.

PMID:
23460123
12.

[Septic shock due to a community acquired Clostridium difficile infection. A case study and a review of the literature].

Bermejo C, Maseda E, Salgado P, Gabilondo G, Gilsanz F.

Rev Esp Anestesiol Reanim. 2014 Apr;61(4):219-22. doi: 10.1016/j.redar.2013.04.005. Epub 2013 Jun 2. Review. Spanish.

PMID:
23735318
13.

Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.

Tleyjeh IM, Bin Abdulhak AA, Riaz M, Alasmari FA, Garbati MA, AlGhamdi M, Khan AR, Al Tannir M, Erwin PJ, Ibrahim T, Allehibi A, Baddour LM, Sutton AJ.

PLoS One. 2012;7(12):e50836. doi: 10.1371/journal.pone.0050836. Epub 2012 Dec 7. Review.

14.

Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies.

Ahn JS, Eom CS, Jeon CY, Park SM.

World J Gastroenterol. 2013 Apr 28;19(16):2560-8. doi: 10.3748/wjg.v19.i16.2560. Review.

15.

Acid-suppressive medications during pregnancy and risk of asthma and allergy in the offspring: protocol for a systematic review.

Devine RE, Sheikh A, Nwaru BI.

NPJ Prim Care Respir Med. 2016 Mar 3;26:16001. doi: 10.1038/npjpcrm.2016.1. Review. No abstract available.

16.

The dangers of proton pump inhibitor therapy.

Owen C, Marks DJ, Banks M.

Br J Hosp Med (Lond). 2014 Jul;75(7):C108-12. Review. No abstract available.

PMID:
25152941
17.

Soft tissue infections caused by spore-forming bacteria in injecting drug users in the United Kingdom.

Brett MM, Hood J, Brazier JS, Duerden BI, Hahné SJ.

Epidemiol Infect. 2005 Aug;133(4):575-82. Review.

18.

Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Fisher L, Fisher A.

Clin Drug Investig. 2017 Jul;37(7):587-624. doi: 10.1007/s40261-017-0519-y. Review.

PMID:
28361440

Supplemental Content

Support Center